2023 annual financial data
Marker Therapeutics 2023 Net margin
Direct answer
Net margin was -248.76%.
Operating income was -14,581,378 USD and net income was -8,236,814 USD.
Operating cash flow was -16,439,961 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,311,133 USD
- Operating income
- -14,581,378 USD
- Net income
- -8,236,814 USD
- Operating cash flow
- -16,439,961 USD